相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Sequence Kernel Association Tests for the Combined Effect of Rare and Common Variants
Iuliana Ionita-Laza et al.
AMERICAN JOURNAL OF HUMAN GENETICS (2013)
HTR1B, ADIPOR1, PPARGC1A, and CYP19A1 and Obesity in a Cohort of Caucasians and African Americans: An Evaluation of Gene-Environment Interactions and Candidate Genes
Todd L. Edwards et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2012)
PGC-1 coactivators in the cardiovascular system
Ian S. Patten et al.
TRENDS IN ENDOCRINOLOGY AND METABOLISM (2012)
Calorie Restriction-like Effects of 30 Days of Resveratrol Supplementation on Energy Metabolism and Metabolic Profile in Obese Humans
Silvie Timmers et al.
CELL METABOLISM (2011)
Association of Single-Nucleotide Polymorphisms From 17 Candidate Genes With Baseline Symptom-Limited Exercise Test Duration and Decrease in Duration Over 20 Years The Coronary Artery Risk Development in Young Adults (CARDIA) Fitness Study
Mark A. Sarzynski et al.
CIRCULATION-CARDIOVASCULAR GENETICS (2010)
Common Variants in 40 Genes Assessed for Diabetes Incidence and Response to Metformin and Lifestyle Intervention in the Diabetes Prevention Program
Kathleen A. Jablonski et al.
DIABETES (2010)
Glucose levels and genetic variants across transcriptional pathways: interaction effects with BMI
C. M. Povel et al.
INTERNATIONAL JOURNAL OF OBESITY (2010)
A method and server for predicting damaging missense mutations
Ivan A. Adzhubei et al.
NATURE METHODS (2010)
PGC-1α-mediated adaptations in skeletal muscle
Jesper Olesen et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
PPARGC1A sequence variation and cardiovascular risk-factor levels: a study of the main genetic effects and gene x environment interactions in children from the European Youth Heart Study
E. C. Brito et al.
DIABETOLOGIA (2009)
Body size and shape changes and the risk of diabetes in the diabetes prevention program
Wilfred Y. Fujimoto et al.
DIABETES (2007)
Genetic variations in PPARD and PPARGC1A determine mitochondrial function and change in aerobic physical fitness and insulin sensitivity during lifestyle intervention
Norbert Stefan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2007)
PPARGC1A coding variation may initiate impaired NEFA clearance during glucose challenge
P. W. Franks et al.
DIABETOLOGIA (2007)
Analysis of PGC-1α variants Gly482Ser and Thr612Met concerning their PPARγ2-coactivation function
Inke Nitz et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
Peroxisome proliferator-activated receptor γ coactivator 1 coactivators, energy hemeostasis, and metabolism
Christoph Handschin et al.
ENDOCRINE REVIEWS (2006)
Peroxisome proliferator-activated receptor-γ coactivator-1 and insulin resistance:: acute effect of fatty acids
J. Hoeks et al.
DIABETOLOGIA (2006)
PGC-1α gene and physical activity in type 2 diabetes mellitus
Paul W. Franks et al.
EXERCISE AND SPORT SCIENCES REVIEWS (2006)
Impaired coactivator activity of the Gly482 variant of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) on mitochondrial transcription factor A (Tfam) promoter
Yon-Sik Choi et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Meta-analysis of the Gly482Ser variant in PPARGC1A in type 2 diabetes and related phenotypes
I Barroso et al.
DIABETOLOGIA (2006)
Efficiency and power in genetic association studies
PIW de Bakker et al.
NATURE GENETICS (2005)
The orphan nuclear receptor SHP regulates PGC-1α expression and energy production in brown adipocytes
L Wang et al.
CELL METABOLISM (2005)
PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men
A Lucia et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
The Gly482Ser missense mutation of the Peroxisome Proliferator-activated receptor gamma coactivator-1 alpha (PGC-1 alpha) gene associates with reduced insulin sensitivity in normal and glucose-intolerant obese subjects
M Fanelli et al.
DISEASE MARKERS (2005)
Common polymorphisms of the PPAR-γ2 (Pro12Ala) and PGC-1α (Gly482Ser) genes are associated with the conversion from impaired glucose tolerance to type 2 diabetes in the STOP-NIDDM trial
L Andrulionytè et al.
DIABETOLOGIA (2004)
PGC-1α genotype modifies the association of volitional nergy expenditure with VO2max
PW Franks et al.
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE (2003)
SIFT: predicting amino acid changes that affect protein function
PC Ng et al.
NUCLEIC ACIDS RESEARCH (2003)
A genetic variation in the PGC-1 gene could confer insulin resistance and susceptibility to Type II diabetes
K Hara et al.
DIABETOLOGIA (2002)
Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin
WC Knowler et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)